Global Extracorporeal CO2 Removal Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Extracorporeal CO2 Removal Devices Market is presumed to reach the market size of nearly USD 174.41 MN by 2032 from USD 85.73 MN in 2023 with a CAGR of 8.21% under the study period 2024 - 2032.

Extracorporeal carbon dioxide removal devices are medical instruments specifically engineered to eliminate carbon dioxide (CO2) from the bloodstream external to the body. These devices play a crucial role in the realm of extracorporeal life support (ECLS) or extracorporeal membrane oxygenation (ECMO), providing temporary assistance to patients facing severe respiratory failure or acute respiratory distress syndrome (ARDS). The primary objective of this technology is to alleviate the strain on the lungs, allowing for healing while ensuring sufficient oxygenation and CO2 removal.

MARKET DYNAMICS

The market for extracorporeal carbon dioxide removal devices is witnessing substantial growth, driven by various factors. The escalating prevalence of severe respiratory failure, acute respiratory distress syndrome (ARDS), and respiratory conditions are amplifying the demand for these devices, offering a critical therapeutic avenue for patients unresponsive to conventional ventilation. Technological advancements play a pivotal role in market expansion, with continuous innovations in device design and membrane technology enhancing efficiency and effectiveness. These advancements contribute to the development of more sophisticated devices that improve performance, safety, and applicability in critical care settings. The increasing awareness of the benefits of managing severe respiratory conditions is contributing to market growth as healthcare professionals recognize its role in providing lung rest and support. The rising incidence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), adds to the demand for these supportive interventions. The COVID-19 pandemic has further emphasized the importance of advanced respiratory support systems, including these devices, in managing severe respiratory distress.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of extracorporeal co2 removal devices. The growth and trends of extracorporeal co2 removal devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the extracorporeal co2 removal devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Extracorporeal CO2 Machines
Disposables
Others

By Application

Acute Respiratory Distress Syndrome (Ards)
Chronic Obstructive Pulmonary Disease (Copd)
Bridge To Lung Transplant
Others

By Access

Venovenous
Arteriovenous

By End-Use

Hospitals
Ambulatory Surgical Centers
Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Extracorporeal CO2 Removal Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Extracorporeal CO2 Removal Devices market include Medtronic, Getinge AB, Xenios AG, ALung Technologies, Inc., ESTOR S.P.A., Medica S.P.A., Aferetica srl. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112113388

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . EXTRACORPOREAL CO2 REMOVAL DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Access
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Extracorporeal CO2 Machines Historic and Forecast Sales by Regions
5.5 Disposables Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Acute Respiratory Distress Syndrome (ARDS) Historic and Forecast Sales by Regions
6.5 Chronic Obstructive Pulmonary Disease (COPD) Historic and Forecast Sales by Regions
6.6 Bridge to Lung Transplant Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY ACCESS

7.1 Overview by Access
7.2 Historical and Forecast Data
7.3 Analysis by Access
7.4 Venovenous Historic and Forecast Sales by Regions
7.5 Arteriovenous Historic and Forecast Sales by Regions

8 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY END-USE

8.1 Overview by End-use
8.2 Historical and Forecast Data
8.3 Analysis by End-use
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
8.6 Clinics Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE EXTRACORPOREAL CO2 REMOVAL DEVICES COMPANIES

10.1. Extracorporeal Co2 Removal Devices Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF EXTRACORPOREAL CO2 REMOVAL DEVICES INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Medtronic
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Getinge AB
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Xenios AG
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. ALung Technologies Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. ESTOR S.P.A.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Medica S.P.A.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Aferetica srl
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies